Individual and Mixture Effects of Selected Pharmaceuticals and Personal Care Products on the Marine Phytoplankton Species Dunaliella tertiolecta
- 11 September 2007
- journal article
- research article
- Published by Springer Nature in Archives of Environmental Contamination and Toxicology
- Vol. 54 (2) , 203-210
Abstract
Pharmaceuticals and personal care products (PPCPs) entering the environment may have detrimental effects on aquatic organisms. Simvastatin, clofibric acid, diclofenac, carbamazepine, fluoxetine, and triclosan represent some of the most commonly used and/or detected PPCPs in aquatic environments. This study analyzed the individual and mixture toxicity of these six PPCPs to the marine phytoplankton species Dunaliella tertiolecta using a standard 96-hour static algal bioassay protocol. All PPCPs tested had a significant effect on D. tertiolecta population cell density. However, of the six PPCPs tested, only triclosan yielded toxicity at typical environmental concentrations. The 96-hour EC50 values for triclosan, fluoxetine, simvastatin, diclofenac, and clofibric acid were 3.55 μg/L, 169.81 μg/L, 22,800 μg/L, 185,690 μg/L, and 224,180 μg/L, respectively. An EC50 value could not be determined for carbamazepine; however, the highest concentration tested (80,000 μg/L) reduced cell density by 42%. Both mixtures tested—simvastatin–clofibric acid and fluoxetine–triclosan—demonstrated additive toxicity. The presence of PPCP mixtures may decrease the toxicity threshold for phytoplankton populations. Detrimental effects on phytoplankton populations could ultimately impact nutrient cycling and food availability to higher trophic levels. The results of this study are a first step toward identifying the risk of PPCPs to estuarine organisms and may benefit environmental resource managers.Keywords
This publication has 26 references indexed in Scilit:
- Preliminary risk assessment of the lipid-regulating pharmaceutical clofibric acid, for three estuarine speciesEnvironmental Research, 2006
- Ecotoxicology of human pharmaceuticalsAquatic Toxicology, 2006
- Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acidEcotoxicology and Environmental Safety, 2004
- Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenacEcotoxicology and Environmental Safety, 2003
- Joint algal toxicity of 16 dissimilarly acting chemicals is predictable by the concept of independent actionAquatic Toxicology, 2003
- Carbamazepine in water: persistence in the environment, ozonation treatment and preliminary assessment on algal toxicityWater Research, 2002
- Pharmaceuticals and personal care products in the environment: agents of subtle change?Environmental Health Perspectives, 1999
- Occurrence of the Pharmaceutical Drug Clofibric Acid and the Herbicide Mecoprop in Various Swiss Lakes and in the North SeaEnvironmental Science & Technology, 1998
- Environmental Hazard Assessment of PharmaceuticalsRegulatory Toxicology and Pharmacology, 1997
- Method for Assessing Additive Toxicity of Chemical Mixtures1977